Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.94M P/E 0.00 EPS this Y 80.10% Ern Qtrly Grth -
Income -8.69M Forward P/E -0.57 EPS next Y 34.90% 50D Avg Chg 11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -44.00%
Dividend N/A Price/Book 0.64 EPS next 5Y - 52W High Chg -97.00%
Recommedations 2.00 Quick Ratio 2.99 Shares Outstanding 3.69M 52W Low Chg 39.00%
Insider Own 0.53% ROA -44.03% Shares Float 3.67M Beta 1.95
Inst Own 2.30% ROE -132.92% Shares Shorted/Prior 11.58K/12.98K Price 7.03
Gross Margin - Profit Margin - Avg. Volume 155,024 Target Price 5.80
Oper. Margin - Earnings Date May 6 Volume 56,065 Change -10.67%
About Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.

Quoin Pharmaceuticals, Ltd. News
03/15/24 Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript
03/13/24 Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
03/07/24 Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
03/05/24 QNRX: Potential Pool of Study Participants Expands; Financial Position Strengths
03/05/24 Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
03/04/24 Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
02/08/24 Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
12/13/23 Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
11/13/23 QNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory Approval
11/10/23 Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call Transcript
11/08/23 Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results
11/03/23 Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET
10/24/23 REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
10/24/23 Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
10/02/23 QNRX: Positive Early Clinical Data, Moving QRX003 Through Multiple Trials
08/09/23 Quoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholders
08/02/23 Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results
07/27/23 Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ET
05/24/23 Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial
05/08/23 Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results
QNRX Chatroom

User Image Betchips Posted - 1 day ago

$QNRX Added today a little to my starter yesterday. Undervalued. MC at $2.6 million and after recent offering they have at least $15 million cash. No brainer

User Image Schiellerup Posted - 1 day ago

$QNRX with this low volume, you could hope the bottom was reached.. fingers crossed 😬

User Image Broken_penny Posted - 1 day ago

$QNRX twits is owned by citadel just so you guys know

User Image WhoDoneIt69 Posted - 2 days ago

$QNRX Betchips 🤡🤡🤡🤡

User Image Schiellerup Posted - 2 days ago

$QNRX where do Stocktwits gets the data on Stock Price from?

User Image BD12 Posted - 2 days ago

$QNRX one of the few greens in the watchlist today.

User Image averagehuman Posted - 2 days ago

$QNRX 💀🥴

User Image Betchips Posted - 2 days ago

$QNRX I’m in… $10 million in cash. $2.6 million market cap. Cash per share at $2.90. Regardless of fundamentals. This is due for a bounce IMO. Providing good entry here

User Image Broken_penny Posted - 2 days ago

$QNRX where’s news

User Image averagehuman Posted - 3 days ago

$QNRX look 👀 at all that volume!! 🤣

User Image Johncash1977 Posted - 3 days ago

$QNRX I’ve been in this company for over two years now. Do not put a penny in it. Suffered to reverse splits and two offerings so far. The procedure is: reverse split, goes down, pump and offering, then dilute and back to under a dollar for the next reverde. This company is fraud. Out of 8.000$ I have 350$ left. Big scam!

User Image averagehuman Posted - 4 days ago

$QNRX

User Image leecoq Posted - 4 days ago

$QNRX https://clinicaltrials.gov/search?lead=Quoin%20Pharmaceuticals just updated

User Image Schiellerup Posted - 4 days ago

$QNRX never going to understand these.. 😅

User Image apache007 Posted - 5 days ago

$QNRX https://quoinpharma.com/company/

User Image apache007 Posted - 1 week ago

User Image BD12 Posted - 1 week ago

$QNRX still looks like it's going lower based on the chart.

User Image ImCrazy Posted - 1 week ago

$QNRX Alumni Capital also bought shares in $QH Quhuo ltd at the same time they bought BCAN shares.

User Image Joshuaiman Posted - 1 week ago

$QNRX 60 cent goes down today the market is bleeding 🩸

User Image WhoDoneIt69 Posted - 1 week ago

$QNRX Wen moon bulls?! How about that float, tell me more about the trials, how about the alumni sale, there is sooooo much FUD on this board from fake bulls. QNRX is a scam, for those still in it.. sell or lose it all slowly, losers choice!

User Image Pokemon69 Posted - 1 week ago

$QNRX probably not a bad news... However, the amount of shares indicates that is some kind of payoff for something from https://www.alumnicapital.com/ [quote]: "During the Special Meeting, shareholders were asked to consider and vote upon the following proposal: to approve the issuance of the maximum number of the Company’s ordinary shares represented by ADSs issuable pursuant to the purchase agreement, dated as of January 25, 2024, with Alumni Capital LP (the “Alumni Issuance Proposal”)"

User Image SmallSharkInBigPond Posted - 1 week ago

$QNRX news👇👇 https://www.sec.gov/Archives/edgar/data/1671502/000110465924045210/tm2411437d1_8k.htm

User Image Broken_penny Posted - 1 week ago

$QNRX lost 3k here pathetic fcks

User Image andrew300 Posted - 1 week ago

$QNRX scam, crooks, scumbags running this company. Should be delisted from nasdaq.

User Image StocksMilkShake Posted - 1 week ago

$QNRX The amount of effort of bashing here ... 😅🤣😅 No shares , but bears are funny. This is a Ph2 bio. with a good drug pipeline.

User Image WhoDoneIt69 Posted - 2 weeks ago

$QNRX such low float! Ready for the squeeze, there’s no way this could go lower!! 😂😂😂 check out the 5 millisecond chart, this thing is primed to pump hard!!! Everyone get in on this now or miss the shuttle to the moon! Guaranteed 12$ next week! If not next week the week after!!! Etc etc. look at the company.. then check out the chart, (zoom out) then take whatever money you were thinking about spending on a scam and shove it up your ass for safe keeping!

User Image Broken_penny Posted - 2 weeks ago

$QNRX done

User Image Broken_penny Posted - 2 weeks ago

$QNRX

User Image BD12 Posted - 2 weeks ago

$QNRX has rebounded off $0.81 a few times now. Seems to be the bottom

User Image WhoDoneIt69 Posted - 2 weeks ago

$QNRX Swiss cherry is a paid pumper and has no position.

Analyst Ratings
Maxim Group Buy Mar 15, 24